The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice
about
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentIncorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.Impaired firing properties of dentate granule neurons in an Alzheimer's disease animal model are rescued by PPARγ agonism.Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.A metabolic prosurvival role for PML in breast cancer.Regulation of the orexigenic neuropeptide, enkephalin, by PPARδ and fatty acids in neurons of the hypothalamus and forebrain.Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.CD 4+ T cells in the pathobiology of neurodegenerative disorders.PPAR Regulation of Inflammatory Signaling in CNS Diseases.Effect of high-fat diets on body composition, lipid metabolism and insulin sensitivity, and the role of exercise on these parameters.Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice.CKD-501, a novel selective PPARγ agonist, shows no carcinogenic potential in ICR mice following oral administration for 104 weeks.PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.Lsd1 prevents age-programed loss of beige adipocytes.Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.Insulin Resistance and Mitochondrial Dysfunction.Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in RatsA novel strategy for designing the selective PPAR agonist by the "sum of activity" model.Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes.High Fat Diet with a High Monounsaturated Fatty Acid and Polyunsaturated/Saturated Fatty Acid Ratio Suppresses Body Fat Accumulation and Weight Gain in Obese Hamsters.Lsd1, a metabolic sensor of environment requirements that prevents adipose tissue from aging.Effect of an acute moderate-exercise session on metabolic and inflammatory profile of PPAR-α knockout mice.Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.Differential actions of PPAR-α and PPAR-β/δ on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice.Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.Integrative analysis of microRNAs and mRNAs revealed regulation of composition and metabolism in Nelore cattle.Associations between Polymorphisms in Genes Involved in Fatty Acid Metabolism and Dietary Fat Intakes
P2860
Q27653305-D49026BD-F21E-4D8B-9182-8FA28FD5C228Q33944259-3AB6157B-7C05-4921-8AA5-676D1596583BQ35178508-48D364E6-B401-4971-A3D8-9FE188A343B0Q36197808-14C0350E-4708-4591-89AA-060690B6E168Q36208566-22811C5A-5B98-452F-9FF1-90DF4547FBF8Q36469944-7AE6A3DC-356A-47A4-B47B-F7786E1425A0Q37047500-2989B985-583A-4EA1-A802-C41F97428F5AQ37210934-DA6EB1AC-9FA6-4B01-AC5D-3DA6523833EBQ37228055-7FC0E4C0-C883-4E54-AB4C-335AE6C9B22BQ37231755-176B4660-973E-4F1A-8B4F-247FB377F3AFQ37923794-D9947477-2165-4651-8C49-4315E9820B61Q38346506-F81095AD-0038-4F57-A5D2-6023578D72F7Q38446975-D98373D0-6C12-4D9E-B263-D347E75F2B18Q38776236-CE1DC827-F534-4525-B38D-DD729053D351Q38810222-BB725E97-4872-4E21-AFF4-E2394ECE9F54Q39090639-31EC3BCF-37F8-42DD-A0BD-6C9952F1D1D6Q39334553-9AA8F788-57A0-41BC-9FCD-6B87C930C4CCQ41457655-ADED9AE2-C0AE-44B7-9061-55E7577C95F9Q42685826-7721A66A-23CA-43C9-8830-7D5DC3566D86Q42964673-83C128B2-A4BD-43B7-8D93-8E5239C070ACQ44305270-78BD835B-C0BB-4C29-8C98-D08CB81CB070Q45580285-D1E456EE-497C-40FA-ADFD-CD95B5786A01Q47309600-AD504CE0-1F99-424F-BD67-CA5AC4CE561FQ47611818-D440D5AA-B1AB-4F31-AC32-1E41EEA5380CQ47862279-FA4A83E6-5203-4CB2-BD21-CCB7D840CA80Q48206129-F9D31605-130F-4AE9-91FB-A950B8E554DDQ49394966-1A89B02A-24D2-4569-8636-151A27ECEC78Q49589296-9E8B3B19-9D02-4B33-B3FF-6EA1091BA928Q57316294-FE555076-4665-460C-9734-35F7FC0CFC67
P2860
The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@en
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@nl
type
label
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@en
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@nl
prefLabel
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@en
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@nl
P2093
P2860
P356
P1433
P1476
The Effect of PPARalpha, PPARd ...... Diet-Induced Obese AKR/J Mice
@en
P2093
Christy S Britt
David C Lobe
Diane M Ignar
Jane G Binz
Joan G Wilson
Michael C Lewis
Naphtali O Milliken
W Wallace Harrington
William R Oliver
P2860
P356
10.1155/2007/97125
P577
2007-01-01T00:00:00Z